vs

Side-by-side financial comparison of Amplitude, Inc. (AMPL) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Amplitude, Inc. is the larger business by last-quarter revenue ($91.4M vs $83.1M, roughly 1.1× PROCEPT BioRobotics Corp). Amplitude, Inc. runs the higher net margin — -19.3% vs -38.1%, a 18.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 17.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 12.2%).

Amplitude is an American publicly traded company that develops digital analytics software. The company was listed publicly on the Nasdaq stock exchange under the ticker symbol AMPL on September 28, 2021.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

AMPL vs PRCT — Head-to-Head

Bigger by revenue
AMPL
AMPL
1.1× larger
AMPL
$91.4M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+3.2% gap
PRCT
20.2%
17.0%
AMPL
Higher net margin
AMPL
AMPL
18.7% more per $
AMPL
-19.3%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
12.2%
AMPL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AMPL
AMPL
PRCT
PRCT
Revenue
$91.4M
$83.1M
Net Profit
$-17.7M
$-31.6M
Gross Margin
74.6%
64.9%
Operating Margin
-18.3%
-4.1%
Net Margin
-19.3%
-38.1%
Revenue YoY
17.0%
20.2%
Net Profit YoY
45.8%
-27.9%
EPS (diluted)
$-0.13
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMPL
AMPL
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$91.4M
$76.4M
Q3 25
$88.6M
$83.3M
Q2 25
$83.3M
$79.2M
Q1 25
$80.0M
$69.2M
Q4 24
$78.1M
$68.2M
Q3 24
$75.2M
$58.4M
Q2 24
$73.3M
$53.4M
Net Profit
AMPL
AMPL
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-17.7M
$-29.8M
Q3 25
$-24.0M
$-21.4M
Q2 25
$-24.7M
$-19.6M
Q1 25
$-22.2M
$-24.7M
Q4 24
$-32.6M
$-18.9M
Q3 24
$-16.9M
$-21.0M
Q2 24
$-23.4M
$-25.6M
Gross Margin
AMPL
AMPL
PRCT
PRCT
Q1 26
64.9%
Q4 25
74.6%
60.6%
Q3 25
73.9%
64.8%
Q2 25
72.6%
65.4%
Q1 25
74.7%
63.9%
Q4 24
74.7%
64.0%
Q3 24
75.1%
63.2%
Q2 24
73.4%
59.0%
Operating Margin
AMPL
AMPL
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-18.3%
-40.6%
Q3 25
-26.0%
-27.8%
Q2 25
-29.0%
-28.0%
Q1 25
-26.8%
-39.7%
Q4 24
-41.2%
-28.9%
Q3 24
-21.4%
-38.4%
Q2 24
-31.7%
-50.3%
Net Margin
AMPL
AMPL
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-19.3%
-39.1%
Q3 25
-27.1%
-25.7%
Q2 25
-29.6%
-24.7%
Q1 25
-27.8%
-35.8%
Q4 24
-41.7%
-27.6%
Q3 24
-22.4%
-35.9%
Q2 24
-31.9%
-48.0%
EPS (diluted)
AMPL
AMPL
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.13
$-0.54
Q3 25
$-0.18
$-0.38
Q2 25
$-0.19
$-0.35
Q1 25
$-0.17
$-0.45
Q4 24
$-0.25
$-0.34
Q3 24
$-0.14
$-0.40
Q2 24
$-0.19
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMPL
AMPL
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$192.0M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$245.3M
$347.7M
Total Assets
$420.7M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMPL
AMPL
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$192.0M
$286.5M
Q3 25
$189.2M
$294.3M
Q2 25
$208.1M
$302.7M
Q1 25
$209.0M
$316.2M
Q4 24
$241.1M
$333.7M
Q3 24
$319.9M
$196.8M
Q2 24
$318.3M
$214.1M
Total Debt
AMPL
AMPL
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
AMPL
AMPL
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$245.3M
$365.9M
Q3 25
$262.2M
$380.3M
Q2 25
$279.5M
$385.8M
Q1 25
$289.5M
$389.2M
Q4 24
$296.6M
$402.2M
Q3 24
$290.0M
$241.2M
Q2 24
$287.3M
$251.8M
Total Assets
AMPL
AMPL
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$420.7M
$508.1M
Q3 25
$438.1M
$511.5M
Q2 25
$456.6M
$513.1M
Q1 25
$445.8M
$519.4M
Q4 24
$445.9M
$534.0M
Q3 24
$445.6M
$374.1M
Q2 24
$445.4M
$374.4M
Debt / Equity
AMPL
AMPL
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMPL
AMPL
PRCT
PRCT
Operating Cash FlowLast quarter
$12.8M
Free Cash FlowOCF − Capex
$12.7M
FCF MarginFCF / Revenue
13.8%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$28.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMPL
AMPL
PRCT
PRCT
Q1 26
Q4 25
$12.8M
$-10.3M
Q3 25
$5.0M
$-6.6M
Q2 25
$20.1M
$-15.0M
Q1 25
$-8.0M
$-17.0M
Q4 24
$3.2M
$-32.4M
Q3 24
$6.2M
$-18.8M
Q2 24
$9.2M
$-15.7M
Free Cash Flow
AMPL
AMPL
PRCT
PRCT
Q1 26
Q4 25
$12.7M
$-12.2M
Q3 25
$4.5M
$-9.5M
Q2 25
$19.5M
$-17.8M
Q1 25
$-8.5M
$-18.8M
Q4 24
$2.4M
$-33.6M
Q3 24
$6.2M
$-19.0M
Q2 24
$8.6M
$-16.8M
FCF Margin
AMPL
AMPL
PRCT
PRCT
Q1 26
Q4 25
13.8%
-15.9%
Q3 25
5.1%
-11.4%
Q2 25
23.4%
-22.5%
Q1 25
-10.6%
-27.2%
Q4 24
3.1%
-49.2%
Q3 24
8.2%
-32.6%
Q2 24
11.8%
-31.4%
Capex Intensity
AMPL
AMPL
PRCT
PRCT
Q1 26
Q4 25
0.2%
2.4%
Q3 25
0.5%
3.4%
Q2 25
0.6%
3.5%
Q1 25
0.5%
2.7%
Q4 24
1.0%
1.7%
Q3 24
0.0%
0.4%
Q2 24
0.8%
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMPL
AMPL

US$55.8M61%
International$35.7M39%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons